Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Canadian Journal of Kidney Health and Disease|May 26, 2017
Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future StudiesNima Madanchi, Martin Bitzan, Tomoko Takano
Presse Medicale (Paris, France : 1983)|January 31, 2012
Management of hemolytic uremic syndromeChantal Loirat, Jeffrey Saland, Martin Bitzan
The Journal of Biological Chemistry|October 1, 2004
Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the Dishevelled familyElena Torban, Hui-Jun Wang, Normand Groulx, et al.
Frontiers in Nephrology|January 31, 2024
Primary cilia and actin regulatory pathways in renal ciliopathiesRita Kalot, Zachary Sentell, Thomas M Kitzler, et al.
The Journal of Urology|August 24, 2010
Is retroperitoneoscopy the gold standard for endoscopic nephrectomy in children on peritoneal dialysis?Konrad M Szymanski, Martin Bitzan, John-Paul Capolicchio
Journal of the American Society of Nephrology : JASN|September 2, 2004
Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndromeMartin Bitzan, Brandi B Bickford, Gregory H Foster
Journal of the American Society of Nephrology : JASN|May 5, 2006
Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant miceAlison Dziarmaga, Michael Eccles, Paul Goodyer
Pediatric Nephrology (Berlin, Germany)|March 21, 2008
Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolutionMartin Bitzan, Jodie D Ouahed, Preetha Krishnamoorthy, et al.
Pediatric Nephrology (Berlin, Germany)|November 8, 2005
Renal hypoplasia: lessons from Pax2Alison Dziarmaga, Jacklyn Quinlan, Paul Goodyer
Pageof 14